Skip Navigation
Skip to contents

Insights Cataract Refract Surg : Insights in Cataract and Refractive Surgery

OPEN ACCESS

Articles

Page Path
HOME > Insights Cataract Refract Surg > Volume 0; > Article
Original Article 백내장 수술과 동시에 수행한 데스메막 내피각막이식술의 임상 결과
이형근1,2, 강성수1,2, 천진석1,2
Clinical results of combined Descemet membrane keratoplasty and cataract operation (triple Descemet membrane keratoplasty) from imported donor corneas
Hyung Keun Lee1,2, Sung Soo Kang1,2, Jin Suk Chun1,2

DOI: https://doi.org/10.63375/icrs.25.014
Published online: October 21, 2025

1Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea

2Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea

Received: 25 September 2025   • Revised: 1 October 2025   • Accepted: 8 October 2025
  • 0 Views
  • 0 Download
  • 0 Crossref
  • 0 Scopus

Purpose
This study reports the clinical outcomes, including changes in visual acuity, refractive error, corneal thickness, and endothelial cell density, after triple Descemet membrane endothelial keratoplasty (DMEK) performed using imported corneas.
Methods
A retrospective study was conducted on 30 eyes of 26 patients who underwent Descemet's membrane keratoplasty concurrently with cataract surgery, referred to as triple DMEK, from January 2023 to June 2025. After routine preoperative examinations for keratoplasty as well as cataract surgery, uneventful DMEK surgery was performed concurrently with cataract surgery. All patients visited the clinic at 1, 3, 6, and 12 months after surgery to observe changes, including uncorrected and best spectacle corrected visual acuity, refractive error, corneal thickness, and endothelial cell density.
Results
Preoperatively, 12 of the 30 eyes had Fuchs corneal endothelial dystrophy and 12 had endothelial failure following phakic intraocular lens implantation. The average observation period for the subjects was 437±263 days. After triple DMEK surgery, the patients' uncorrected visual acuity gradually improved from 0.73±0.6 (logMAR) before surgery to 0.65±0.54 at 3 months and 0.29±0.26 at 1 year (P<0.001). The change in corneal thickness was 565.7±70.0 µm before surgery, 535.2±44.2 µm at 3 months after surgery, 549.7±73.5 µm at 6 months, and 549.7±73.5 µm at 12 months, but no statistical significance was found compared to before surgery at any time point (P>0.05). The endothelial cell density was 798±363 cells/mm2 before surgery, 1,479±475 cells/mm2 at 3 months after surgery, 1,456±456 cells/mm2 at 6 months, 1,332±346 cells/mm2 at 12 months, and 1,399±519 cells/mm2 at the last visit (P<0.001).
Conclusion
Triple DMEK surgery, which is performed for various corneal diseases, is relatively safe. No significant endothelial damage, refractive changes, or visual acuity abnormalities were observed up to one year after surgery. Future prospective studies including a larger number of participants are warranted to evaluate the safety and clinical outcomes of triple DMEK using imported corneas.

Figure

Insights Cataract Refract Surg : Insights in Cataract and Refractive Surgery
Close layer
TOP